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Administration of potent mouse interferon preparations to newborn mice induces 
an acute syndrome characterized by inhibition of growth, delay in the maturation of 
several organs, extensive liver cell degeneration, and death (1). An identical syndrome 
is seen in different strains of mice infected at birth with lymphocytic choriomeningitis 
(LCM) 1 virus (i.e.,  impaired growth, delay in organ maturation, liver cell degenera- 
tion, and death in the first  few weeks of life.)  We have shown that the induction of 
endogenous interferon  by LCM virus is  an  important  pathogenetic factor, because 
injection  of a  potent  anti-interferon  globulin,  which  neutralized  the  virus-induced 
endogenous interferon, markedly inhibited this acute syndrome (2).  In the course of 
these studies, we noted (in accord with previous observations [3, 4]) that the incidence 
of mortality in suckling mice infected at  birth  with  LCM virus varies considerably 
between different strains of mice. Thus, we observed:  100% mortality for C3H and 
C57BI/6; 94%  for CBA; 79% for AKR; 36%  for Swiss;  10% for DBA/2; and 0%  for 
BALB/C mice. Because we have suggested that interferon is in large part responsible 
for the different manisfestations of LCM virus disease in suckling mice (2), it seemed 
of interest  to  determine  whether  this  varying severity of disease  in  three  different 
strains of mice (BALB/c, Swiss,  and C3H mice) was related either to the amount of 
endogenous interferon  produced after virus infection or to a  different sensitivity to 
this endogenous interferon. The results of these studies are reported herein. 
Materials and Methods 
Mice.  Pathogen-free  C3H,  CBA,  AKR,  and  C57BI/6  mice  were obtained  from  IFFA 
CREDO, France. Swiss, C3H, and BALB/c mice were obtained from the Institut de Recherches 
sur le Cancer, Villejuif, Paris, France. 
Virus:  LCM virus strain  CIPV 76001 of the Pasteur  Institute was titered  by intracerebral 
inoculation of 3-wk-old Swiss mice. The titer of LCM virus was 108 median lethal doses (LDs0) 
per gram of brain homogenate.  Newborn  mice were inoculated  in the first 24 h of life in the 
* Supported in part by grants from the Direction des Recherches, Etudes et Techniques (contract 78-34- 
210), Institut National de la Sant~ et de la Recherche M~dicale (ATP 62-78-94, 44-76-76/3; 47-77-79). 
i Abbreviations used in this paper: LCM, lymphocytic  choriomeningitis; LDs0, mean lethal dose. 
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interscapular region subcutaneously with  10  4.7  LD~0 of virus in 0.05  ml. Control  mice were 
injected with an extract of normal brain. 
Determination of Virus and Interferon Levels in Plasma and Liver.  There were on the average eight 
suckling mice per litter. In the days after viral inoculation, litters were sacrificed; the plasma 
from mice in each litter were pooled and titered for virus or interferon as previously described 
(2). 
Virus in the liver (50% wt/vol homogenate) was titered by plaque assay in cultures of L cell 
monolayers (5).  In our experiments 1 plaque-forming unit is approximately the equivalent of 
25 mouse LDs0. 
Preparations and Assay of Mouse Interferon.  Mouse C-243 cell interferon was prepared, concen- 
trated, and partially purified as previously described (6). Interferon was assayed as previously 
described (7) on monolayers of mouse L cells challenged with 100 median tissue culture infective 
doses (TCIDs0) of vesicular stomatitis virus. All plasma and liver homogenates were kept at pH 
4 for 24 h to inactivate LCM virus before assay. Mouse interferon units quoted are as measured 
in our laboratory and one of our units equal four mouse interferon reference units. 
Histology.  Tissues were fixed in Bouin's solution and stained with hematoxylin and eosin. 
Results 
Disease in BALB/c,  Swiss, and C3H Suckling Mice Inoculated at Birth with LCM  Virus 
GROWTH CURVE.  To determine the effect of LCM virus on the growth of suckling 
mice, litters of BALB/c, Swiss, or C3H  mice were left uninoculated, inoculated with 
normal brain extract, or inoculated with  10  4.7  LDs0 of LCM  virus.  All LCM  virus- 
infected  mice  grew  normally  for  the  1st  wk  of life  (Fig.  1).  Thereafter,  a  slight 
inhibition of growth was observed for virus-infected BALB/c mice, a greater inhibition 
for Swiss mice, whereas virus-infected C3H  mice lost weight  (Fig.  1). 
MORTALITY.  The results of several experiments presented in Fig. 2  show that 0/ 
115  (0%) BALB/c mice, 47/129  (36%)  Swiss mice, and 87/87  (100%)  C3H mice, died 
in  the  1st  mo of life after  inoculation of 10 't"7 LDs0  of LCM  virus.  C3H  mice  died 
sooner than Swiss mice (Fig. 2). 
HISTOLOGIC  EXAMINATION  OF THE LIVER.  In accord with our previous observations 
(2), the only gross and histologic abnormalities in virus-infected suckling mice were 
noted in the liver. In two experiments LCM  virus-infected BALB/c, Swiss, and C3H 
mice were sacrificed and  histologic sections of the liver were  examined at  different 
intervals or at  a  given time  (9th  d)  (Table I).  In both experiments the lesions were 
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FIG.  1.  Cumulative  daily increase in mean weight (grams) for uninoculated  BALB/c, Swiss, and 
C3H suckling mice (open symbols) or inoculated with  10  4.7 LDs0 of LCM virus (closed symbols). RIVIERE  ET AL.  635 
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Fro.  2.  Mortality in suckling C3H ";  Swiss &; and BALB/c •  mice inoculated subcutaneously at 
birth with 10  4.7 logLDr~j  of LCM virus. (The figures in parentheses indicate the number of newborn 
mice per experiment.) 
TABLE  I 
Incidence and Severity of Liver Lesions  in LCM  Virus-infected Mice Sacrificed 
at 9d 
Mouse strain 
No. of mice with histo-  Mean liver 
logic liver lesions/No, of  score:[: 
mice inoculated* 
BALB/c  12/15  1.1 
Swiss  10/12  1.8 
C3H He/VF  10/10  3.5 
C3H/ICO  10/I0  4.0 
* There were six sections  of liver per mouse examined by two investigators.  All 
slides were coded. 
:l: Mean liver score based on total number of mice. Severity of lesions based on 
a score of 0-4.  1+ -- Steatosis without necrosis; 2+ = steatosis and loci of 
subcapsular necrosis; 3+ = foci of necrosis extending into body of liver (25- 
50% of liver parenchyma); 4+ = massive liver cell necrosis involving >75% 
of liver parenchyma. 
discrete in BALB/c mice (Fig. 3 B), of intermediate severity in Swiss mice (Fig. 3 C), 
and massive in C3H mice (Fig. 3 D  and Table I). 
TITERS OF VIRUS AND INTERFERON  IN PLASMA AND LIVER.  The results of the preceding 
experiments showed that  LCM virus disease was mild in BALB/c mice, of interme- 
diate severity in Swiss mice, and most marked in C3H mice (as judged by effects on 
growth, incidence, and severity of liver lesions and percentage mortality). As shown 
in Fig. 4 (upper panel) and Fig. 5 this different pattern of disease was not attributable 
to differences in LCM virus multiplication because plasma and liver virus titers were 
similar in all three strains of mice, (as high in BALB/c mice as in C3H mice). 
A striking difference however was observed in the amount and duration of endog- 
enous  blood  interferon  induced  in  these  strains  of  mice  (lower  panel,  Fig.  4). 
BALB/c mice had a  very low interferon response limited for the most part to the 3rd 
d;  Swiss mice had greater amounts of interferon on the 3rd and 4th d.  In contrast, 
C3H  mice  had  high  levels  of  plasma  interferon  on  the  3rd  to  the  6th  d.  Liver 
interferon titers  were  uniformly low  and  inconsistent (due  to  cell  toxicity of liver FIG.  3.  Sections of liver from BALB/c, Swiss, and C3H  mice injected at birth with  104.7 LD~ of 
LCM  virus and  sacrificed  on  the  9th  d.  Stained  with hematoxylin and  eosin  (X  63).  (A)  From 
uninoculated BALB/c mouse. (B)  From virus-infected BALB/c mouse. Note subcapsular necrosis 
(2+  lesion).  (C)  From  virus-infected  Swiss  moose.  Note  extensive  necrosis  but  large  areas  of 
parenchyma are spared (3+ lesion).  (D) From virus-infected C3H mouse. Note massive necrosis (4+ 
lesion).  (For lesion scores see legend in Table I.) 
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Fxc.  4.  Plasma titers of virus and interferon in BALB/c , Swiss, and C3H  mice infected at birth 
with  10  4.7 Ls0 of LCM  virus. Each symbol indicates a  pool of plasma from a  litter of suckling mice 
(average,  10 mice). 
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Titer of virus in the  livers of BALB/c, Swiss, and C3H  mice infected at birth with  10  4.7 
LD~o of LCM virus. Each symbol indicates the virus titer from an individual mouse. (+) C3H mice 
died between the 7th and 9th d; Swiss mice died after the  10th d. All BALB/c mice survived. 
extracts,  low titers were difficult to interpret).  No significant difference was observed 
between the different strains. 
DECREASED MORTALITY IN LCM VIRUS-INFECTED SUCKLING C3H MICE INOCULATED WITH 
ANTI-INTERFERON GLOBULIN.  Because  administration  of anti-interferon  globulin  had 638  LYMPHOCYTIC CHORIOMENINGITIS  AND  ENDOGENOUS  INTERFERON 
previously been shown to decrease the incidence of mortality in virus-infected Swiss 
mice (2) we undertook the same type of experiment in virus-infected C3H mice. 
Newborn C3H mice inoculated with  105 LD~0 of LCM virus were injected on day 
0  and  day 3  with  potent  sheep anti-mouse interferon  globulin  (titer 8  ×  10  -5)  (8). 
Whereas  100%  of virus-infected control  C3H mice died,  (9th  to  12th  d),  only 6/28 
(21%)  of  anti-mouse  interferon  globulin-treated  mice  died.  These  six  mice  died 
between the  15th and the 27th d. 
Exogenous  Interferon  Can  Induce Disease  in  BALB/c  Mice.  Although  the  minimal 
disease observed in LCM virus-infected BALB/c mice appeared to be related to their 
minimal  interferon  response,  it  was  of  interest  to  determine  the  sensitivity  of 
BALB/c  mice to  daily  administration  of interferon.  Accordingly,  in  five litters  11 
newborn BALB/c mice were injected daily for 7 d with 0.05 ml of a mouse C-243 cell 
interferon  preparation  (6)  having  a  titer  of  1.6  ×  10  -6.  Eight  litter  mates  were 
inoculated with a control preparation. 
Interferon  treatment  inhibited  the  growth  of suckling  BALB/c  mice.  Thus,  the 
mean  weights  (in  grams)  on  the  8th  d  of life  for interferon-treated  suckling  mice 
compared  with  control  inoculated  litter  mates  for  the  five  litters  were:  interferon 
treated/control:  4/6.1;  2.3/4.4;  2.3/4.0;  3.4/5.3;  and  2.2/3.0.  Extensive  liver  cell 
necrosis was seen in interferon-treated mice sacrificed on the 8th d. 
Discussion 
The severity of disease observed in suckling mice injected at birth with LCM virus 
depends  on  the  mouse  strain  (4).  In  our  studies  BALB/c  mice  were  relatively 
unaffected: they grew almost as well as uninfected mice, they had only minimal liver 
lesions and  none died.  In contrast,  virus-infected C3H  mice grew poorly, they had 
extensive  liver cell  degeneration,  and  all  mice  died.  An  intermediate  pattern  was 
observed  in  Swiss  mice.  In  referring  to  the  variation  in  mortality  of LCM  virus- 
infected suckling mice of different  strains Von Boehmer and co-workers stated  "we 
know of no cause which satisfactorily explains the differences between mouse strains 
or the fluctuation within strains" (4). In agreement with the findings of Von Boehmer 
et al.  (4)  we found no difference in virus titers in plasma or liver between the three 
strains of mice (Figs. 4 and 5). 
However, despite similar titers of virus in the plasma and liver, clear-cut differences 
in the amount of endogenous interferon produced and the duration of interferonemia 
was  observed  for  the  three  strains  of mice.  Thus  BALB/c  mice  produced  small 
amounts  of interferon  detectable  in  the  plasma  mostly  on  the  3rd  d;  Swiss  mice 
produced  more  interferon  detectable  on  the  3rd  and  4th  d,  whereas  C3H  mice 
produced larger amounts of interferon and interferonemia lasted between the 3rd and 
6th  d  (Fig.  4).  Our  results  suggest  therefore  that  the  amplitude  of the  interferon 
response  in  C3H  mice is  in  large part  responsible  for the severity of LCM  disease. 
This interpretation  is further supported by experiments showing a  marked decrease 
in  the  incidence  of mortality  in  virus-infected  C3H  mice when  they were  injected 
with  a  potent  anti-mouse  interferon  globulin  (Results).  Furthermore,  the  relative 
resistance of BALB/c mice was not caused by insensitivity to interferon action because 
exogenous interferon did inhibit their growth and did induce comparable liver lesions. 
We suggest therefore that the minimal disease occurring in BALB/c mice was related 
to their minimal interferon response. RIVIERE  ET  AL.  639 
These experiments also suggest that there is a genetic control for the production of 
interferon in suckling mice infected with  LCM virus.  De Maeyer and his associates 
have  described  four  loci  which  determine  the  interferon  response  in  mice  after 
injection  of Newcastle disease  (9),  mouse  mammary (10),  and  Sendai  (11)  viruses. 
Work is in progress to determine whether the gene(s)  controlling the production  of 
interferon after infection with LCM virus is related to these previously described loci. 
There is no question that interferon plays a beneficial role in most viral infections, 
and  when  administered,  can confer considerable  protection  against  viral infection. 
Our work emphasizes however, that potent biologic substances such as interferon can 
also be associated with untoward effects. Thus, in the study presented herein, it is the 
host response in C3H mice manifested as production of large amounts of interferon 
that  proves injurious  (100%  mortality), whereas  the minimal  interferon  response of 
BALB/c mice is associated with  100% survival. In LCM virus disease of adult mice, 
it is also the host response in the form of sensitized lymphocytes that appears to be 
responsible for disease  (12-14).  Thus,  in  both suckling and  adult  mice, LCM  viral 
multiplication itself is apparently well tolerated  (15), but it is the host response that 
is not tolerated. Recently, Hooks et al. (16) have found elevated levels of interferon in 
the  sera  of patients  with  severe  systemic  lupus  erythematosis,  and  suggested  the 
possibility that this interferon may play a pathogenetic role. Ida and co-workers (17) 
have suggested  that  the  interferon  produced  in  the course of respiratory  infections 
may be responsible for some of the "allergic" manifestations. If we may extrapolate 
the results of our study and the extensive studies of De Maeyer et al. (9-11), it seems 
possible that  there is  a  genetic control  for the  production  of interferon  to different 
viruses in man. Individuals may vary in the extent of their interferon response to a 
given  viral  infection  and  in  their  sensitivity  to  the  effects  of interferon.  In  most 
instances  this interferon  response will prove beneficial, but  possibly there are some 
instances where too much interferon will prove injurious in a given individual. 
Summary 
A  marked  difference  was  observed  in  the  severity  of  disease  in  lymphocytic 
choriomeningitis  (LCM)  virus-infected  suckling  BALB/c,  Swiss,  and  C3H  mice. 
BALB/c  mice  had  minimal  liver  lesions  and  none  died,  whereas  C3H  mice  had 
extensive liver lesions and all mice died.  An  intermediate  pattern was observed for 
Swiss mice (36% mortality). Although  there was no difference in the titers of LCM 
virus in the plasma or liver between these three strains of mice, there was a  marked 
difference in the amount of interferon produced and the duration of interferonemia. 
C3H mice produced more interferon than Swiss mice which produced more interferon 
than BALB/c mice~ indicating a direct correlation between the amount of interferon 
induced by LCM virus and the extent of disease. Inoculation of a potent anti-mouse 
interferon  globulin  markedly  reduced  the  incidence  of mortality  in  virus-infected 
C3H mice. BALB/c mice were as sensitive to the effects of interferon as C3H mice 
because daily administration of potent interferon preparations did induce disease in 
this strain. This ensemble of results supports our contention that endogenous interferon 
is  in  large  part  responsible  for  the  manifestations  of acute  LCM  virus  disease  in 
suckling mice. 640  LYMPHOCYTIC CHORIOMENINGITIS  AND ENDOGENOUS INTERFERON 
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